Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCertara, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

Certara, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Pinnacle 21 Enterprise: Your fast track to submission-ready clinical data
    Sep 25, 2026Certara

    The post Pinnacle 21 Enterprise: Your fast track to submission-ready clinical data appeared first on Certara.

  • CODEX Clinical Outcomes Databases Hidradenitis Suppurativa (HS)
    Sep 25, 2026Certara

    Explore Certara's CODEX Hidradenitis Suppurativa database ~43 studies with key efficiency and safety endpoints (HiSCR50, AN count, DLQI, HS-PGA skin pain responder, IHS4 score) The post CODEX Clinical Outcomes Databases Hidradenitis Suppurativa (HS) appeared first on Certara.

  • CODEX Clinical Outcomes Databases Chronic Heart Failure (CHF)
    Sep 25, 2026Certara

    Explore Certara's CODEX Chronic Heart Failure database ~200 studies with key efficiency and safety endpoints (LVEF, all cause mortality, NT-proBNP,BNP) The post CODEX Clinical Outcomes Databases Chronic Heart Failure (CHF) appeared first on Certara.

  • Marvin is now fully integrated as the unified drawing experience across Certara’s Discovery portfolio
    Sep 25, 2026Certara

    Marvin, Certara's chemical sketching tool, is now integrated across Design Hub, Compound Registration, Compliance Checker, and D360 — one editor, every workflow. The post Marvin is now fully integrated as the unified drawing experience across Certara’s Discovery portfolio appeared first on Certara.

  • Enable AI to Access your PK Data: What’s New in Integral 7.1
    Sep 24, 2026Certara

    [event_date_range] The post Enable AI to Access your PK Data: What’s New in Integral 7.1 appeared first on Certara.

  • From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs
    Sep 23, 2026Certara

    New CPT review by Certara's Karen Rowland Yeo & Piet van der Graaf shows how PBPK and QSP models serve as regulatory-grade NAMs, backed by FDA/EMA case studies. The post From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs appeared first on Certara.

  • From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management
    Sep 23, 2026Certara

    [event_date_range] The post From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management appeared first on Certara.

  • Modeling effective doses of therapeutic antibodies targeting clustered surface receptors
    Sep 23, 2026Certara

    Discover how semi-mechanistic PK/receptor-occupancy modeling reveals that lower, subcutaneous doses, not maximum tolerated doses, optimize TNFR2 antibody efficacy. The post Modeling effective doses of therapeutic antibodies targeting clustered surface receptors appeared first on Certara.

  • Model-Informed Strategies for ADC Development
    Sep 22, 2026Certara

    Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen regulatory strategy, and support lifecycle value. The post Model-Informed Strategies for ADC Development appeared first on Certara.

  • Pistoia Alliance 2026 CSCS Conference
    Sep 18, 2026Certara

    [event_date_range] The post Pistoia Alliance 2026 CSCS Conference appeared first on Certara.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$8.83Close · Sep 22, 2026